Skip to main content
. 2020 Oct 27;10(4):1751–1761. doi: 10.3233/JPD-202058

Table 2.

Change in CGI-S and CGI-I scores over 8 weeks of treatment with pimavanserin as monotherapy vs adjunctive therapy

Monotherapy Adjunctive Therapy
CGI-S n Change from baseline n Change from baseline
LS mean (SE) LS mean (SE)
  Week 2 20 –1.1 (0.18) 23 –0.9 (0.23)
  Week 4 20 –1.5 (0.19) 19 –1.5 (0.21)
  Week 6 18 –1.7 (0.20) 21 –1.5 (0.18)
  Week 8 19 –1.9 (0.21) 20 –1.6 (0.22)
CGI-I n LS mean (SE) n LS mean (SE)
  Week 2 19 2.4 (0.21) 23 2.6 (0.26)
  Week 4 20 2.1 (0.20) 19 2.3 (0.23)
  Week 6 18 1.9 (0.19) 21 2.2 (0.22)
  Week 8 19 1.8 (0.20) 20 2.2 (0.25)

Clinicians rated the severity of the patient’s depression and improvement of symptoms from baseline on a scale of 1–7, with lower scores indicating improvement. CGI-I, Clinical Global Impression–Improvement; CGI-S, Clinical Global Impression–Severity; LS, least squares; SE, standard error.